In recent years, physicians have made great strides forward in the treatment of Marfan patients. Although there is no cure for the underlying genetic defect, Marfan patients are closely monitored to see if their condition is deteriorating. If the aorta becomes too enlarged, preventive surgery may be recommended. Other aggressive treatment options have helped to push the average lifespan of Marfan patients over 60 years. Life expectancy is longer among women than men.